Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4519227
Max Phase: Preclinical
Molecular Formula: C34H38O16S
Molecular Weight: 734.73
Molecule Type: Unknown
Associated Items:
ID: ALA4519227
Max Phase: Preclinical
Molecular Formula: C34H38O16S
Molecular Weight: 734.73
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc2cc(CO[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](S[C@@H]4O[C@H](CO)[C@H](O)[C@H](OCc5cc6ccc(OC)cc6oc5=O)[C@H]4O)[C@@H]3O)c(=O)oc2c1
Standard InChI: InChI=1S/C34H38O16S/c1-43-19-5-3-15-7-17(31(41)47-21(15)9-19)13-45-29-25(37)23(11-35)49-33(27(29)39)51-34-28(40)30(26(38)24(12-36)50-34)46-14-18-8-16-4-6-20(44-2)10-22(16)48-32(18)42/h3-10,23-30,33-40H,11-14H2,1-2H3/t23-,24-,25+,26+,27-,28-,29+,30+,33+,34+/m1/s1
Standard InChI Key: DNOXSHLEGBCFLX-JBKGHAIWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 734.73 | Molecular Weight (Monoisotopic): 734.1881 | AlogP: 0.00 | #Rotatable Bonds: 12 |
Polar Surface Area: 237.18 | Molecular Species: NEUTRAL | HBA: 17 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.29 | CX Basic pKa: | CX LogP: -0.58 | CX LogD: -0.58 |
Aromatic Rings: 4 | Heavy Atoms: 51 | QED Weighted: 0.11 | Np Likeness Score: 0.52 |
1. Rajput VK, MacKinnon A, Mandal S, Collins P, Blanchard H, Leffler H, Sethi T, Schambye H, Mukhopadhyay B, Nilsson UJ.. (2016) A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model., 59 (17): [PMID:27500311] [10.1021/acs.jmedchem.6b00957] |
Source(1):